Diagnostic Criteria for Diabetes Insipidus

Introduction to Diabetes Insipidus Diagnosis

The American College of Physicians recommends that diabetes insipidus be diagnosed based on the simultaneous presence of inappropriately dilute urine (osmolality <200 mOsm/kg) combined with high-normal or elevated serum sodium and elevated serum osmolality (≥300 mOsm/kg) 1, 2, 3
The Endocrine Society suggests that a urine osmolality of 220 mOsm/kg falls in an indeterminate range that can occur with many conditions, including partial dehydration, chronic kidney disease, or early stages of various renal disorders, and does not definitively establish DI 1
The European Society of Endocrinology states that true diabetes insipidus requires urine osmolality definitively <200 mOsm/kg in the setting of serum hyperosmolality 1
The normal anion gap and absence of hypernatremia further argue against active DI, as recommended by the American College of Physicians 1, 2

The International Society of Nephrology suggests that patients with Bartter syndrome can develop a secondary form of nephrogenic diabetes insipidus, presenting a therapeutic dilemma where salt supplementation would worsen polyuria and risk hypernatremic dehydration 4
The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines indicate that salt supplementation is specifically contraindicated in patients with hypernatremic dehydration and concomitant urine osmolality lower than plasma 4
The low urinary electrolytes across the board (sodium, chloride, potassium) point toward a renal tubular disorder affecting electrolyte handling, not a primary water balance disorder, as stated by the European Renal Association 4

The American College of Physicians recommends a water deprivation test followed by desmopressin administration as the gold standard for diagnosis if DI is still suspected clinically 1
The Endocrine Society suggests that plasma copeptin measurement can differentiate between central DI (copeptin <21.4 pmol/L) and nephrogenic DI (copeptin >21.4 pmol/L) if testing proceeds 1, 2

The International Society of Nephrology recommends that patients with Bartter syndrome require evaluation for salt-wasting tubulopathies, not diabetes insipidus workup 4
The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines suggest that serum electrolytes including potassium, magnesium, and bicarbonate should be assessed to evaluate for metabolic alkalosis typical of Bartter syndrome 4
The European Society of Nephrology recommends plasma renin and aldosterone levels to confirm the diagnosis of Bartter syndrome 4
Genetic testing is recommended if Bartter syndrome is confirmed, as stated by the European Renal Association 4
The American College of Physicians suggests avoiding salt restriction, as these patients typically require pharmacologic doses (5-10 mmol/kg/d) of sodium chloride supplementation unless they develop secondary nephrogenic DI with hypernatremia 4